Edition:
United States

Nephros Inc (NEPH.OB)

NEPH.OB on OTC BB

0.37USD
24 Mar 2017
Change (% chg)

$-0.00 (-1.33%)
Prev Close
$0.38
Open
$0.38
Day's High
$0.38
Day's Low
$0.36
Volume
12,650
Avg. Vol
29,906
52-wk High
$0.60
52-wk Low
$0.24

Latest Key Developments (Source: Significant Developments)

Nephros Q1 revenue $590,000
Wednesday, 11 May 2016 04:20pm EDT 

Nephros Inc : Nephros reports first quarter 2016 financial results .Q1 revenue $590,000.  Full Article

Nephros Inc announces retirement of chairman
Wednesday, 30 Dec 2015 04:15pm EST 

Nephros Inc:Announced that the company's Chairman, Lawrence Centella, has decided to retire from the Nephros Board of Directors, effective December 31, 2015.  Full Article

Nephros Inc enters into purchase agreement with Lincoln Park Capital Fund, LLC
Monday, 27 Jul 2015 07:30am EDT 

Nephros Inc:Says that it has entered into a purchase agreement with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor.Under the terms of the purchase agreement, over a 36-month term, Nephros will have the right and the sole discretion to sell to LPC up to $10 million worth of shares of Nephros common stock in amounts as set forth in the agreement.Says nephros will control the timing and amount of any future investment and LPC will be obligated to make purchases in accordance with the agreement.  Full Article

Nephros Inc closes $1.2 mln private placement
Tuesday, 19 May 2015 04:00pm EDT 

Nephros Inc:Closes private placement offering for gross proceeds of about $1.23 million, wherein issued about 1.83 million shares of common stock.  Full Article

Nephros announces $1.2 mln private placement
Tuesday, 12 May 2015 08:30am EDT 

Nephros Inc:Had signed definitive agreements for the sale of about $1.2 mln of the Company's common stock at a price of $0.67 per share, or about 1.8 mln shares.In addition, the Company will issue to the investors warrants to purchase about 0.9 million shares of common stock. The warrants have an exercise price of $0.85 per share and are exercisable for 5 years from the closing date.The offering is expected to close on or about May 15, subject to satisfying customary closing conditions.  Full Article

Nephros Inc appoints Daron Evans as President and Chief Executive Officer and lawrence centella as Chairman
Wednesday, 15 Apr 2015 10:34am EDT 

Nephros Inc:Says that Daron Evans has been appointed President and Chief Executive Officer.Effective upon Evans's appointment, Paul Mieyal stepped down as acting CEO of Nephros and will remain as a member of the company's board of directors.Additionally, Lawrence Centella has been appointed Chairman of the Board of Directors.  Full Article

More From Around the Web

BRIEF-Nephros appoints Andrew Astor as CFO

* Nephros announces appointment of Andrew Astor as chief financial officer